RxDoctor Payments Data

Virginia Inthavong

Family · Modesto, CANPI 1932741139

Payments from drug & device makers

$2,675in general payments, 2019–2025

Across 85 payments — averaging $31.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$374
  • Novo Nordisk$317
  • Johnson & Johnson$287
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$286
  • Sanofi$224
  • Incyte Corporation$193
  • plus $993 from 19 others

What the payments were for

  • Food & beverage$2,38489%
  • Education$29111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,675 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$40,819
JardianceEmpagliflozin28$25,931
EliquisApixaban12$9,968
XareltoRivaroxaban16$9,656
Fluticasone-VilanterolFluticasone/Vilanterol16$5,312
Breo ElliptaFluticasone/Vilanterol15$5,037
Albuterol Sulfate HfaAlbuterol Sulfate81$3,292
Gabapentin97$1,095
Levothyroxine Sodium45$592
Trazodone Hcl24$530
Rosuvastatin Calcium20$470
Atorvastatin Calcium63$468
Pantoprazole Sodium29$376
Cyclobenzaprine Hcl21$359
Ibuprofen32$351

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$317$40,81940 claims
Boehringer IngelheimJardiance$52$25,93128 claims
PfizerEliquis$42$9,96812 claims
Johnson & JohnsonXarelto$287$9,65616 claims
Lilly USA, LLCOlanzapine$374$25711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,634 family providers in California.

Other family in Modesto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →